Nearly shut down in 2021, Pune ZP school among 4 shortlisted from India for World's Best School Prize 2025
A Zilla Parishad (ZP) school in Pune district's Jalindarnagar village has been shortlisted among global finalists for the World's Best School Prize 2025 in the category of Community Collaboration in education.
Three other Indian schools – one each from Karnataka, Haryana, and Uttar Pradesh – have also been shortlisted under various categories for the award organised by UK-based international education platform T4 Education.
The ZP school in Pune's Khed taluka was on the brink of closure in 2021 with just three to four students on its rolls. The school has since undergone a major transformation under the leadership of President's award-winning teacher Dattatray Ware, who was transferred here the same year. Today, it serves 120 students in classes 1 to 8, supported by just two full-time teachers, and stands as an example of how community engagement can redefine effective school education with limited resources.
Talking about this journey, Ware said, 'The real change began when the villagers came forward. Many even donated their land to expand school infrastructure. We are running a skill-based education programme in 22 trades with help from villagers, many of whom are working professionals in varied sectors and volunteer as educators for classes related to their trade.'
'This is a ZP school run by the government but our motto is to not wait until the government provides. The school, with help from villagers, is proactive in obtaining facilities or creating the resources required for our students.'
The school has established academic partnerships with institutions like Indian Space Research Organisation (Isro) and Indian Institutes of Technology (IITs), introducing students to the science and technology sector. Exposure to foreign languages and advanced mathematics skills are also part of the curriculum.
Among the school's innovative approaches is the 'Vishay Mitra' (subject friend) initiative. This is a peer-learning model, where senior students mentor juniors, helping clarify doubts in a comfortable, student-led setting. 'Sometimes children hesitate to ask questions to teachers or in front of the entire class. With small group settings led by a friend from a senior class, they open up easily,' Ware explained.
The World's Best School Prize is an initiative launched in response to the COVID-19 crisis, and aims to spotlight schools that are creating meaningful changes in classrooms and on the outside. Voting to choose the best schools will take place till July 9 and this year's winners will be announced in October.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
32 minutes ago
- Time of India
How dengue mosquitoes outsmart even scientists
How dengue mosquitoes outsmart even scientists - their secret hunting techniques revealed Chethan Kumar TNN Updated: Jun 23, 2025, 18:12 IST IST While the dengue mosquito is a smarter predator than previously thought — it can detect you with its legs, too — Indian scientists have detected that a stealthy group of immune cells could be the unsung heroes in fighting the infection It's tough to outsmart a mosquito out for your blood. Here's some consolation. The buzzing insect outsmarts even supersmart scientists. 'Aedes aegypti', the mosquito behind dengue , Zika, and yellow fever , hunts down its prey — humans — primarily by its sense of smell. So, when researchers from the Rockefeller University stripped Aedes aegypti of its primary olfactory gene, Orco — knocking out their sense of smell — they reckoned the female mosquito will lose her hunting instinct. But she was smarter than they were. As a new study published in Science Advances details, when deprived of their olfactory power, Aedes use their ability to sense body heat. Typically, it's the mosquito's antennae that detects odours and heat. But Orco mutants deploy their forelegs to detect human skin temperature.
&w=3840&q=100)
Business Standard
39 minutes ago
- Business Standard
Gene-edited rice may pose IPR risks, scientists say in letter to PM
A group of scientists calling themselves the 'Agricultural Scientists Manch' have written to the Prime Minister denouncing the recent release of India's first genetically edited rice varieties, stating that the technology used—CRISPR-Cas9—could face intellectual property rights (IPR) issues, potentially negating the real advantage Indian farmers could derive from genome-edited rice. The Centre has repeatedly clarified that all IPR issues related to gene editing are being thoroughly addressed, and a panel has been formed for this purpose. It has also assured that the government will acquire the necessary licences for gene-editing technologies and that no additional burden will fall on Indian farmers. The letter, signed by nearly 20 former and current scientists including Sharad Nimbalkar, former vice-chancellor of Panjabrao Deshmukh Agriculture University, Akola, stated that although CRISPR-Cas9 is a highly precise technology, it can still go off-track, potentially causing severe undesirable consequences. It also warned that large-scale use of gene-edited rice could contaminate India's native rice germplasm. The scientists further expressed concern that unresolved IPR issues could lead to Indian farmers becoming dependent on foreign seed technologies. They added that the newly released rice varieties were cleared without adequate evaluation. The letter was also marked to Agriculture Minister Shivraj Singh Chouhan, Environment Minister Bhupender Yadav, Health Minister Jagat Prakash Nadda and Science and Technology Minister Jitendra Singh. Last month, in a significant development, the government released two genome-edited rice varieties for the first time in the country. These varieties are expected to increase per-hectare yields by up to 30 per cent and mature 15–20 days earlier than existing varieties.
Time of India
an hour ago
- Time of India
Man with stage 4 cancer beats rare mutation in Gurgaon
Gurgaon: Cancer is a relentless enemy but not an invincible one, says Dr Pooja Babbar, under whose watch a 38-year-old man with a rare and aggressive head and neck cancer has made a remarkable recovery. Tired of too many ads? go ad free now The patient with Stage 4 mucoepidermoid carcinoma battled the disease for over two years, with no success from surgeries or conventional chemotherapy at a Jaipur-based hospital. But doctors under the care of Babbar — consultant and unit head, medical oncology at Fortis Hospital, Manesar — treated the patient, who has now beaten the disease after receiving advanced targeted therapy. Entrectinib, an oral targeted therapy, attacks cancer cells based on their genetic profile. Dr Babbar told TOI, "Oral targeted therapies offer a focused approach by attacking specific molecules in cancer cells, reducing damage to healthy tissue. In this case, the treatment led to a dramatic reduction — around 60–70% — in tumour size within two months and near-complete regression by the fourth month." Earlier this year, when the man had arrived at Fortis Hospital, the cancer progressed significantly, with a large tumour causing visible disfigurement on the right side of his face and neck and spreading to his lungs, doctors said. The patient was in severe pain, experienced significant weight loss and was emotionally distressed. Under the care of Babbar, the patient was assessed using next generation sequencing (NGS), a form of molecular testing that revealed a rare gene mutation found in fewer than 1% of cancer cases. This finding enabled doctors to shift from conventional chemotherapy to a personalised treatment plan using Entrectinib. Tired of too many ads? go ad free now Despite the advanced stage of the disease, the personalised therapy not only halted the cancer's progression but also brought visible and measurable improvement in a short period. He is now stable and continues to undergo maintenance therapy with regular follow-ups. Dr Babbar laid stress on the importance of timely diagnosis and genetic profiling in delivering effective cancer treatment. "If there was further delay in personalised intervention, his survival chances would have declined drastically," she said.
